DuoBody-CD3xCD20 induces potent T-cell-mediated killing of malignant B cells in preclinical models and provides opportunities for subcutaneous dosing
Key Points
Key points are not available for this paper at this time.
Abstract
Genmab.
Like
Bookmark
Share
View Full Paper
Like
Bookmark
Share
View Full Paper
DuoBody-CD3xCD20 induces potent T-cell-mediated killing of malignant B cells in preclinical models and provides opportunities for subcutaneous dosing | Synapse
Functional CD47/signal regulatory protein alpha (SIRPα) interaction is required for optimal human T- and natural killer- (NK) cell homeostasis in vivo2011 · 196 citations